Cite
HARVARD Citation
Baar, J. et al. (2015). Pilot trial of a type I - polarized autologous dendritic cell vaccine incorporating tumor blood vessel antigen-derived peptides in patients with metastatic breast cancer. Journal for immunotherapy of cancer. 3 (1), p. 1. [Online].